NCT01378884

The Use of Domperidone for Gastroparesis

Monitoring Study for the Use of Gastroparesis for Patient Who Have Failed Standard Therapy

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Allegiance Health · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether domperidone can be used safely and effectively for patient with gastroparesis.

Detailed description

Individuals who have been diagnosed with gastroparesis and have failed at least one standard therapy will be offered to trial domperidone as a possible remedy to their condition. Patients on the medication will be expected to to be followed by the physician at 3 months, 6 months 12months, and then annually while on the medication. Any change or significant adverse reaction to the medication or in their condition should be reported immediately to their physician.

Conditions

• Gastroparesis

Interventions

Type	Name	Description
DRUG	Domperidone	Patient to receive treatment with Domperidone

Timeline

• Start date: 2010-03-01
• Primary completion: 2012-03-01
• Completion: 2014-03-01
• First posted: 2011-06-23
• Last updated: 2013-03-19